Epidemiological monitoring of raloxifene involves both pre- and post-market surveillance to track its effectiveness and safety. Large-scale cohort studies, like the [Fracture Intervention Trial](https://clinicaltrials.gov/ct2/show/NCT00000611), provide valuable data on long-term outcomes and adverse events. These studies inform guidelines and help optimize treatment protocols.
